secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2022-03-09T23:59:59+00:00
Accession:  0001077183-22-000047
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics announces retirement of COO Cardoza; appoints Sholehvar as President of Clinical Services
--------------------------------------------------------------------------------

- George Cardoza, President and COO Lab Ops, to retire effective March 31, 2022.
- Dr. Steven Brodie appointed interim President of Lab Operations.
- Dr. David Sholehvar appointed President, Clinical Services, effective March 14, 2022.
- Sholehvar compensation: $435K base, 50% bonus, $750K equity grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000047/0001077183-22-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718322000047/neo-20220309.htm
  HTML page:      https://secwatch.observer/filing/0001077183-22-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer